BioCorRx
Pharmaceuticals,
Inc.
Joseph
DeSanto
MD
Net loss
Average Non-controlling interest percentage of profit/losses
Net loss attributable to the non-controlling interest
Balance, December 31, 2023
Balance, June 30, 2024
Balance, December 31, 2022
Balance, June 30, 2023
No definition available.